Advertisement

Index by author

April 01, 2004; Volume 32,Issue 4

B

  1. Bahn, Andrew

    1. EXPRESSION STUDIES AND FUNCTIONAL CHARACTERIZATION OF RENAL HUMAN ORGANIC ANION TRANSPORTER 1 ISOFORMS
      Andrew Bahn, Christian Ebbinghaus, Diana Ebbinghaus, Evgeni G. Ponimaskin, Laszlo Fuzesï, Gerhard Burckhardt and Yohannes Hagos
      Drug Metabolism and Disposition April 2004, 32 (4) 424-430; DOI: https://doi.org/10.1124/dmd.32.4.424

  2. Bélanger, Alain

    1. AMINO ACID RESIDUE ILE211 IS ESSENTIAL FOR THE ENZYMATIC ACTIVITY OF HUMAN UDP-GLUCURONOSYLTRANSFERASE 1A10 (UGT1A10)
      Isabelle Martineau, André Tchernof and Alain Bélanger
      Drug Metabolism and Disposition April 2004, 32 (4) 455-459; DOI: https://doi.org/10.1124/dmd.32.4.455

  3. Bellward, Gail D.

    1. THE EFFECT OF CIMETIDINE ON DEXTROMETHORPHAN O-DEMETHYLASE ACTIVITY OF HUMAN LIVER MICROSOMES AND RECOMBINANT CYP2D6
      Maria Madeira, Marc Levine, Thomas K. H. Chang, Ahmad Mirfazaelian and Gail D. Bellward
      Drug Metabolism and Disposition April 2004, 32 (4) 460-467; DOI: https://doi.org/10.1124/dmd.32.4.460

  4. Bhathena, Anahita

    1. TRANSCRIPTIONAL SUPPRESSION OF CYTOCHROME P450 GENES BY ENDOGENOUS AND EXOGENOUS CHEMICALS
      David S. Riddick, Chunja Lee, Anahita Bhathena, Yoav E. Timsit, Po-Yung Cheng, Edward T. Morgan, Russell A. Prough, Sharon L. Ripp, Kristy K. Michael Miller, Asmeen Jahan and John Y. L. Chiang
      Drug Metabolism and Disposition April 2004, 32 (4) 367-375; DOI: https://doi.org/10.1124/dmd.32.4.367

  5. Black, Meredith L.

    1. COMPARISON OF PREDICTION METHODS FOR IN VIVO CLEARANCE OF (S,S)-3-[3-(METHYLSULFONYL)PHENYL]-1-PROPYLPIPERIDINE HYDROCHLORIDE, A DOPAMINE D2 RECEPTOR ANTAGONIST, IN HUMANS
      Shinji Yamazaki, Lisa N. Toth, Meredith L. Black and J. Neil Duncan
      Drug Metabolism and Disposition April 2004, 32 (4) 398-404; DOI: https://doi.org/10.1124/dmd.32.4.398

  6. Burckhardt, Gerhard

    1. EXPRESSION STUDIES AND FUNCTIONAL CHARACTERIZATION OF RENAL HUMAN ORGANIC ANION TRANSPORTER 1 ISOFORMS
      Andrew Bahn, Christian Ebbinghaus, Diana Ebbinghaus, Evgeni G. Ponimaskin, Laszlo Fuzesï, Gerhard Burckhardt and Yohannes Hagos
      Drug Metabolism and Disposition April 2004, 32 (4) 424-430; DOI: https://doi.org/10.1124/dmd.32.4.424

C

  1. Chang, Thomas K. H.

    1. THE EFFECT OF CIMETIDINE ON DEXTROMETHORPHAN O-DEMETHYLASE ACTIVITY OF HUMAN LIVER MICROSOMES AND RECOMBINANT CYP2D6
      Maria Madeira, Marc Levine, Thomas K. H. Chang, Ahmad Mirfazaelian and Gail D. Bellward
      Drug Metabolism and Disposition April 2004, 32 (4) 460-467; DOI: https://doi.org/10.1124/dmd.32.4.460

  2. Cheng, Po-Yung

    1. TRANSCRIPTIONAL SUPPRESSION OF CYTOCHROME P450 GENES BY ENDOGENOUS AND EXOGENOUS CHEMICALS
      David S. Riddick, Chunja Lee, Anahita Bhathena, Yoav E. Timsit, Po-Yung Cheng, Edward T. Morgan, Russell A. Prough, Sharon L. Ripp, Kristy K. Michael Miller, Asmeen Jahan and John Y. L. Chiang
      Drug Metabolism and Disposition April 2004, 32 (4) 367-375; DOI: https://doi.org/10.1124/dmd.32.4.367

  3. Chiang, John Y. L.

    1. TRANSCRIPTIONAL SUPPRESSION OF CYTOCHROME P450 GENES BY ENDOGENOUS AND EXOGENOUS CHEMICALS
      David S. Riddick, Chunja Lee, Anahita Bhathena, Yoav E. Timsit, Po-Yung Cheng, Edward T. Morgan, Russell A. Prough, Sharon L. Ripp, Kristy K. Michael Miller, Asmeen Jahan and John Y. L. Chiang
      Drug Metabolism and Disposition April 2004, 32 (4) 367-375; DOI: https://doi.org/10.1124/dmd.32.4.367

  4. Chiba, Kan

    1. KEY STRUCTURAL FEATURES OF LIGANDS FOR ACTIVATION OF HUMAN PREGNANE X RECEPTOR
      Kaoru Kobayashi, Saeko Yamagami, Tomoaki Higuchi, Masakiyo Hosokawa and Kan Chiba
      Drug Metabolism and Disposition April 2004, 32 (4) 468-472; DOI: https://doi.org/10.1124/dmd.32.4.468

D

  1. Davies, Carwyn

    1. ASSESSMENT OF ARGININE 97 AND LYSINE 72 AS DETERMINANTS OF SUBSTRATE SPECIFICITY IN CYTOCHROME P450 2C9 (CYP2C9)
      Carwyn Davies, Katey Witham, Justin R. Scott, Andrew Pearson, James J. DeVoss, Sandra E. Graham and Elizabeth M. J. Gillam
      Drug Metabolism and Disposition April 2004, 32 (4) 431-436; DOI: https://doi.org/10.1124/dmd.32.4.431

  2. DeVoss, James J.

    1. ASSESSMENT OF ARGININE 97 AND LYSINE 72 AS DETERMINANTS OF SUBSTRATE SPECIFICITY IN CYTOCHROME P450 2C9 (CYP2C9)
      Carwyn Davies, Katey Witham, Justin R. Scott, Andrew Pearson, James J. DeVoss, Sandra E. Graham and Elizabeth M. J. Gillam
      Drug Metabolism and Disposition April 2004, 32 (4) 431-436; DOI: https://doi.org/10.1124/dmd.32.4.431

  3. Duncan, J. Neil

    1. COMPARISON OF PREDICTION METHODS FOR IN VIVO CLEARANCE OF (S,S)-3-[3-(METHYLSULFONYL)PHENYL]-1-PROPYLPIPERIDINE HYDROCHLORIDE, A DOPAMINE D2 RECEPTOR ANTAGONIST, IN HUMANS
      Shinji Yamazaki, Lisa N. Toth, Meredith L. Black and J. Neil Duncan
      Drug Metabolism and Disposition April 2004, 32 (4) 398-404; DOI: https://doi.org/10.1124/dmd.32.4.398

E

  1. Ebbinghaus, Christian

    1. EXPRESSION STUDIES AND FUNCTIONAL CHARACTERIZATION OF RENAL HUMAN ORGANIC ANION TRANSPORTER 1 ISOFORMS
      Andrew Bahn, Christian Ebbinghaus, Diana Ebbinghaus, Evgeni G. Ponimaskin, Laszlo Fuzesï, Gerhard Burckhardt and Yohannes Hagos
      Drug Metabolism and Disposition April 2004, 32 (4) 424-430; DOI: https://doi.org/10.1124/dmd.32.4.424

  2. Ebbinghaus, Diana

    1. EXPRESSION STUDIES AND FUNCTIONAL CHARACTERIZATION OF RENAL HUMAN ORGANIC ANION TRANSPORTER 1 ISOFORMS
      Andrew Bahn, Christian Ebbinghaus, Diana Ebbinghaus, Evgeni G. Ponimaskin, Laszlo Fuzesï, Gerhard Burckhardt and Yohannes Hagos
      Drug Metabolism and Disposition April 2004, 32 (4) 424-430; DOI: https://doi.org/10.1124/dmd.32.4.424

F

  1. Fuzesï, Laszlo

    1. EXPRESSION STUDIES AND FUNCTIONAL CHARACTERIZATION OF RENAL HUMAN ORGANIC ANION TRANSPORTER 1 ISOFORMS
      Andrew Bahn, Christian Ebbinghaus, Diana Ebbinghaus, Evgeni G. Ponimaskin, Laszlo Fuzesï, Gerhard Burckhardt and Yohannes Hagos
      Drug Metabolism and Disposition April 2004, 32 (4) 424-430; DOI: https://doi.org/10.1124/dmd.32.4.424

G

  1. Galetin, Aleksandra

    1. HUMAN UDP-GLUCURONOSYLTRANSFERASES: ISOFORM SELECTIVITY AND KINETICS OF 4-METHYLUMBELLIFERONE AND 1-NAPHTHOL GLUCURONIDATION, EFFECTS OF ORGANIC SOLVENTS, AND INHIBITION BY DICLOFENAC AND PROBENECID
      Verawan Uchaipichat, Peter I. Mackenzie, Xiao-Hui Guo, Dione Gardner-Stephen, Aleksandra Galetin, J. Brian Houston and John O. Miners
      Drug Metabolism and Disposition April 2004, 32 (4) 413-423; DOI: https://doi.org/10.1124/dmd.32.4.413

  2. Gardner-Stephen, Dione

    1. HUMAN UDP-GLUCURONOSYLTRANSFERASES: ISOFORM SELECTIVITY AND KINETICS OF 4-METHYLUMBELLIFERONE AND 1-NAPHTHOL GLUCURONIDATION, EFFECTS OF ORGANIC SOLVENTS, AND INHIBITION BY DICLOFENAC AND PROBENECID
      Verawan Uchaipichat, Peter I. Mackenzie, Xiao-Hui Guo, Dione Gardner-Stephen, Aleksandra Galetin, J. Brian Houston and John O. Miners
      Drug Metabolism and Disposition April 2004, 32 (4) 413-423; DOI: https://doi.org/10.1124/dmd.32.4.413

  3. Gillam, Elizabeth M. J.

    1. ASSESSMENT OF ARGININE 97 AND LYSINE 72 AS DETERMINANTS OF SUBSTRATE SPECIFICITY IN CYTOCHROME P450 2C9 (CYP2C9)
      Carwyn Davies, Katey Witham, Justin R. Scott, Andrew Pearson, James J. DeVoss, Sandra E. Graham and Elizabeth M. J. Gillam
      Drug Metabolism and Disposition April 2004, 32 (4) 431-436; DOI: https://doi.org/10.1124/dmd.32.4.431

  4. Graham, Sandra E.

    1. ASSESSMENT OF ARGININE 97 AND LYSINE 72 AS DETERMINANTS OF SUBSTRATE SPECIFICITY IN CYTOCHROME P450 2C9 (CYP2C9)
      Carwyn Davies, Katey Witham, Justin R. Scott, Andrew Pearson, James J. DeVoss, Sandra E. Graham and Elizabeth M. J. Gillam
      Drug Metabolism and Disposition April 2004, 32 (4) 431-436; DOI: https://doi.org/10.1124/dmd.32.4.431

  5. Griffiths, W. J.

    1. A PROTEOMIC APPROACH TO THE IDENTIFICATION OF CYTOCHROME P450 ISOFORMS IN MALE AND FEMALE RAT LIVER BY NANOSCALE LIQUID CHROMATOGRAPHY-ELECTROSPRAY IONIZATION-TANDEM MASS SPECTROMETRY
      S. Nisar, C. S. Lane, A. F. Wilderspin, K. J. Welham, W. J. Griffiths and L. H. Patterson
      Drug Metabolism and Disposition April 2004, 32 (4) 382-386; DOI: https://doi.org/10.1124/dmd.32.4.382

  6. Guo, Xiao-Hui

    1. HUMAN UDP-GLUCURONOSYLTRANSFERASES: ISOFORM SELECTIVITY AND KINETICS OF 4-METHYLUMBELLIFERONE AND 1-NAPHTHOL GLUCURONIDATION, EFFECTS OF ORGANIC SOLVENTS, AND INHIBITION BY DICLOFENAC AND PROBENECID
      Verawan Uchaipichat, Peter I. Mackenzie, Xiao-Hui Guo, Dione Gardner-Stephen, Aleksandra Galetin, J. Brian Houston and John O. Miners
      Drug Metabolism and Disposition April 2004, 32 (4) 413-423; DOI: https://doi.org/10.1124/dmd.32.4.413

H

  1. Hagos, Yohannes

    1. EXPRESSION STUDIES AND FUNCTIONAL CHARACTERIZATION OF RENAL HUMAN ORGANIC ANION TRANSPORTER 1 ISOFORMS
      Andrew Bahn, Christian Ebbinghaus, Diana Ebbinghaus, Evgeni G. Ponimaskin, Laszlo Fuzesï, Gerhard Burckhardt and Yohannes Hagos
      Drug Metabolism and Disposition April 2004, 32 (4) 424-430; DOI: https://doi.org/10.1124/dmd.32.4.424

  2. He, Kan

    1. INCORPORATION OF AN OXYGEN FROM WATER INTO TROGLITAZONE QUINONE BY CYTOCHROME P450 AND MYELOPEROXIDASE
      Kan He, Rasmy E. Talaat and Thomas F. Woolf
      Drug Metabolism and Disposition April 2004, 32 (4) 442-446; DOI: https://doi.org/10.1124/dmd.32.4.442

  3. Higuchi, Tomoaki

    1. KEY STRUCTURAL FEATURES OF LIGANDS FOR ACTIVATION OF HUMAN PREGNANE X RECEPTOR
      Kaoru Kobayashi, Saeko Yamagami, Tomoaki Higuchi, Masakiyo Hosokawa and Kan Chiba
      Drug Metabolism and Disposition April 2004, 32 (4) 468-472; DOI: https://doi.org/10.1124/dmd.32.4.468

  4. Horie, Toshiharu

    1. ENDOTOXIN-MEDIATED DISTURBANCE OF HEPATIC CYTOCHROME P450 FUNCTION AND DEVELOPMENT OF ENDOTOXIN TOLERANCE IN THE RAT MODEL OF DEXTRAN SULFATE SODIUM-INDUCED EXPERIMENTAL COLITIS
      Yasuhiro Masubuchi and Toshiharu Horie
      Drug Metabolism and Disposition April 2004, 32 (4) 437-441; DOI: https://doi.org/10.1124/dmd.32.4.437

  5. Hosokawa, Masakiyo

    1. KEY STRUCTURAL FEATURES OF LIGANDS FOR ACTIVATION OF HUMAN PREGNANE X RECEPTOR
      Kaoru Kobayashi, Saeko Yamagami, Tomoaki Higuchi, Masakiyo Hosokawa and Kan Chiba
      Drug Metabolism and Disposition April 2004, 32 (4) 468-472; DOI: https://doi.org/10.1124/dmd.32.4.468

  6. Houston, J. Brian

    1. HUMAN UDP-GLUCURONOSYLTRANSFERASES: ISOFORM SELECTIVITY AND KINETICS OF 4-METHYLUMBELLIFERONE AND 1-NAPHTHOL GLUCURONIDATION, EFFECTS OF ORGANIC SOLVENTS, AND INHIBITION BY DICLOFENAC AND PROBENECID
      Verawan Uchaipichat, Peter I. Mackenzie, Xiao-Hui Guo, Dione Gardner-Stephen, Aleksandra Galetin, J. Brian Houston and John O. Miners
      Drug Metabolism and Disposition April 2004, 32 (4) 413-423; DOI: https://doi.org/10.1124/dmd.32.4.413

  7. Howald, William

    1. QUANTITATIVE CONTRIBUTION OF CYP2D6 AND CYP3A TO OXYCODONE METABOLISM IN HUMAN LIVER AND INTESTINAL MICROSOMES
      Bojan Lalovic, Brian Phillips, Linda L. Risler, William Howald and Danny D. Shen
      Drug Metabolism and Disposition April 2004, 32 (4) 447-454; DOI: https://doi.org/10.1124/dmd.32.4.447

J

  1. Jahan, Asmeen

    1. TRANSCRIPTIONAL SUPPRESSION OF CYTOCHROME P450 GENES BY ENDOGENOUS AND EXOGENOUS CHEMICALS
      David S. Riddick, Chunja Lee, Anahita Bhathena, Yoav E. Timsit, Po-Yung Cheng, Edward T. Morgan, Russell A. Prough, Sharon L. Ripp, Kristy K. Michael Miller, Asmeen Jahan and John Y. L. Chiang
      Drug Metabolism and Disposition April 2004, 32 (4) 367-375; DOI: https://doi.org/10.1124/dmd.32.4.367

K

  1. Kamataki, Tetsuya

    1. CLONING CYP2D21 AND CYP3A22 CDNAS FROM LIVER OF MINIATURE PIGS
      Tsutomu Sakuma, Tsukasa Shimojima, Kiyoshi Miwa and Tetsuya Kamataki
      Drug Metabolism and Disposition April 2004, 32 (4) 376-378; DOI: https://doi.org/10.1124/dmd.32.4.376

  2. Kobayashi, Kaoru

    1. KEY STRUCTURAL FEATURES OF LIGANDS FOR ACTIVATION OF HUMAN PREGNANE X RECEPTOR
      Kaoru Kobayashi, Saeko Yamagami, Tomoaki Higuchi, Masakiyo Hosokawa and Kan Chiba
      Drug Metabolism and Disposition April 2004, 32 (4) 468-472; DOI: https://doi.org/10.1124/dmd.32.4.468

  3. Kraemer, Thomas

    1. IDENTIFICATION OF HUMAN CYTOCHROME P450 2D6 AS MAJOR ENZYME INVOLVED IN THE O-DEMETHYLATION OF THE DESIGNER DRUG P-METHOXYMETHAMPHETAMINE
      Roland F. Staack, Denis S. Theobald, Liane D. Paul, Dietmar Springer, Thomas Kraemer and Hans H. Maurer
      Drug Metabolism and Disposition April 2004, 32 (4) 379-381; DOI: https://doi.org/10.1124/dmd.32.4.379

L

  1. Lalovic, Bojan

    1. QUANTITATIVE CONTRIBUTION OF CYP2D6 AND CYP3A TO OXYCODONE METABOLISM IN HUMAN LIVER AND INTESTINAL MICROSOMES
      Bojan Lalovic, Brian Phillips, Linda L. Risler, William Howald and Danny D. Shen
      Drug Metabolism and Disposition April 2004, 32 (4) 447-454; DOI: https://doi.org/10.1124/dmd.32.4.447

  2. Lane, C. S.

    1. A PROTEOMIC APPROACH TO THE IDENTIFICATION OF CYTOCHROME P450 ISOFORMS IN MALE AND FEMALE RAT LIVER BY NANOSCALE LIQUID CHROMATOGRAPHY-ELECTROSPRAY IONIZATION-TANDEM MASS SPECTROMETRY
      S. Nisar, C. S. Lane, A. F. Wilderspin, K. J. Welham, W. J. Griffiths and L. H. Patterson
      Drug Metabolism and Disposition April 2004, 32 (4) 382-386; DOI: https://doi.org/10.1124/dmd.32.4.382

  3. Lee, Chunja

    1. TRANSCRIPTIONAL SUPPRESSION OF CYTOCHROME P450 GENES BY ENDOGENOUS AND EXOGENOUS CHEMICALS
      David S. Riddick, Chunja Lee, Anahita Bhathena, Yoav E. Timsit, Po-Yung Cheng, Edward T. Morgan, Russell A. Prough, Sharon L. Ripp, Kristy K. Michael Miller, Asmeen Jahan and John Y. L. Chiang
      Drug Metabolism and Disposition April 2004, 32 (4) 367-375; DOI: https://doi.org/10.1124/dmd.32.4.367

  4. Levine, Marc

    1. THE EFFECT OF CIMETIDINE ON DEXTROMETHORPHAN O-DEMETHYLASE ACTIVITY OF HUMAN LIVER MICROSOMES AND RECOMBINANT CYP2D6
      Maria Madeira, Marc Levine, Thomas K. H. Chang, Ahmad Mirfazaelian and Gail D. Bellward
      Drug Metabolism and Disposition April 2004, 32 (4) 460-467; DOI: https://doi.org/10.1124/dmd.32.4.460

M

  1. Mackenzie, Peter I.

    1. HUMAN UDP-GLUCURONOSYLTRANSFERASES: ISOFORM SELECTIVITY AND KINETICS OF 4-METHYLUMBELLIFERONE AND 1-NAPHTHOL GLUCURONIDATION, EFFECTS OF ORGANIC SOLVENTS, AND INHIBITION BY DICLOFENAC AND PROBENECID
      Verawan Uchaipichat, Peter I. Mackenzie, Xiao-Hui Guo, Dione Gardner-Stephen, Aleksandra Galetin, J. Brian Houston and John O. Miners
      Drug Metabolism and Disposition April 2004, 32 (4) 413-423; DOI: https://doi.org/10.1124/dmd.32.4.413

  2. Madeira, Maria

    1. THE EFFECT OF CIMETIDINE ON DEXTROMETHORPHAN O-DEMETHYLASE ACTIVITY OF HUMAN LIVER MICROSOMES AND RECOMBINANT CYP2D6
      Maria Madeira, Marc Levine, Thomas K. H. Chang, Ahmad Mirfazaelian and Gail D. Bellward
      Drug Metabolism and Disposition April 2004, 32 (4) 460-467; DOI: https://doi.org/10.1124/dmd.32.4.460

  3. Martineau, Isabelle

    1. AMINO ACID RESIDUE ILE211 IS ESSENTIAL FOR THE ENZYMATIC ACTIVITY OF HUMAN UDP-GLUCURONOSYLTRANSFERASE 1A10 (UGT1A10)
      Isabelle Martineau, André Tchernof and Alain Bélanger
      Drug Metabolism and Disposition April 2004, 32 (4) 455-459; DOI: https://doi.org/10.1124/dmd.32.4.455

  4. Masubuchi, Yasuhiro

    1. ENDOTOXIN-MEDIATED DISTURBANCE OF HEPATIC CYTOCHROME P450 FUNCTION AND DEVELOPMENT OF ENDOTOXIN TOLERANCE IN THE RAT MODEL OF DEXTRAN SULFATE SODIUM-INDUCED EXPERIMENTAL COLITIS
      Yasuhiro Masubuchi and Toshiharu Horie
      Drug Metabolism and Disposition April 2004, 32 (4) 437-441; DOI: https://doi.org/10.1124/dmd.32.4.437

  5. Maurer, Hans H.

    1. IDENTIFICATION OF HUMAN CYTOCHROME P450 2D6 AS MAJOR ENZYME INVOLVED IN THE O-DEMETHYLATION OF THE DESIGNER DRUG P-METHOXYMETHAMPHETAMINE
      Roland F. Staack, Denis S. Theobald, Liane D. Paul, Dietmar Springer, Thomas Kraemer and Hans H. Maurer
      Drug Metabolism and Disposition April 2004, 32 (4) 379-381; DOI: https://doi.org/10.1124/dmd.32.4.379

  6. Miller, Kristy K. Michael

    1. TRANSCRIPTIONAL SUPPRESSION OF CYTOCHROME P450 GENES BY ENDOGENOUS AND EXOGENOUS CHEMICALS
      David S. Riddick, Chunja Lee, Anahita Bhathena, Yoav E. Timsit, Po-Yung Cheng, Edward T. Morgan, Russell A. Prough, Sharon L. Ripp, Kristy K. Michael Miller, Asmeen Jahan and John Y. L. Chiang
      Drug Metabolism and Disposition April 2004, 32 (4) 367-375; DOI: https://doi.org/10.1124/dmd.32.4.367

  7. Miners, John O.

    1. HUMAN UDP-GLUCURONOSYLTRANSFERASES: ISOFORM SELECTIVITY AND KINETICS OF 4-METHYLUMBELLIFERONE AND 1-NAPHTHOL GLUCURONIDATION, EFFECTS OF ORGANIC SOLVENTS, AND INHIBITION BY DICLOFENAC AND PROBENECID
      Verawan Uchaipichat, Peter I. Mackenzie, Xiao-Hui Guo, Dione Gardner-Stephen, Aleksandra Galetin, J. Brian Houston and John O. Miners
      Drug Metabolism and Disposition April 2004, 32 (4) 413-423; DOI: https://doi.org/10.1124/dmd.32.4.413

  8. Mirfazaelian, Ahmad

    1. THE EFFECT OF CIMETIDINE ON DEXTROMETHORPHAN O-DEMETHYLASE ACTIVITY OF HUMAN LIVER MICROSOMES AND RECOMBINANT CYP2D6
      Maria Madeira, Marc Levine, Thomas K. H. Chang, Ahmad Mirfazaelian and Gail D. Bellward
      Drug Metabolism and Disposition April 2004, 32 (4) 460-467; DOI: https://doi.org/10.1124/dmd.32.4.460

  9. Miwa, Kiyoshi

    1. CLONING CYP2D21 AND CYP3A22 CDNAS FROM LIVER OF MINIATURE PIGS
      Tsutomu Sakuma, Tsukasa Shimojima, Kiyoshi Miwa and Tetsuya Kamataki
      Drug Metabolism and Disposition April 2004, 32 (4) 376-378; DOI: https://doi.org/10.1124/dmd.32.4.376

  10. Morgan, Edward T.

    1. TRANSCRIPTIONAL SUPPRESSION OF CYTOCHROME P450 GENES BY ENDOGENOUS AND EXOGENOUS CHEMICALS
      David S. Riddick, Chunja Lee, Anahita Bhathena, Yoav E. Timsit, Po-Yung Cheng, Edward T. Morgan, Russell A. Prough, Sharon L. Ripp, Kristy K. Michael Miller, Asmeen Jahan and John Y. L. Chiang
      Drug Metabolism and Disposition April 2004, 32 (4) 367-375; DOI: https://doi.org/10.1124/dmd.32.4.367

N

  1. Nikolic, Dejan

    1. NEW METABOLIC PATHWAYS FOR FLAVANONES CATALYZED BY RAT LIVER MICROSOMES
      Dejan Nikolic and Richard B. van Breemen
      Drug Metabolism and Disposition April 2004, 32 (4) 387-397; DOI: https://doi.org/10.1124/dmd.32.4.387

  2. Nisar, S.

    1. A PROTEOMIC APPROACH TO THE IDENTIFICATION OF CYTOCHROME P450 ISOFORMS IN MALE AND FEMALE RAT LIVER BY NANOSCALE LIQUID CHROMATOGRAPHY-ELECTROSPRAY IONIZATION-TANDEM MASS SPECTROMETRY
      S. Nisar, C. S. Lane, A. F. Wilderspin, K. J. Welham, W. J. Griffiths and L. H. Patterson
      Drug Metabolism and Disposition April 2004, 32 (4) 382-386; DOI: https://doi.org/10.1124/dmd.32.4.382

P

  1. Patterson, L. H.

    1. A PROTEOMIC APPROACH TO THE IDENTIFICATION OF CYTOCHROME P450 ISOFORMS IN MALE AND FEMALE RAT LIVER BY NANOSCALE LIQUID CHROMATOGRAPHY-ELECTROSPRAY IONIZATION-TANDEM MASS SPECTROMETRY
      S. Nisar, C. S. Lane, A. F. Wilderspin, K. J. Welham, W. J. Griffiths and L. H. Patterson
      Drug Metabolism and Disposition April 2004, 32 (4) 382-386; DOI: https://doi.org/10.1124/dmd.32.4.382

  2. Paul, Liane D.

    1. IDENTIFICATION OF HUMAN CYTOCHROME P450 2D6 AS MAJOR ENZYME INVOLVED IN THE O-DEMETHYLATION OF THE DESIGNER DRUG P-METHOXYMETHAMPHETAMINE
      Roland F. Staack, Denis S. Theobald, Liane D. Paul, Dietmar Springer, Thomas Kraemer and Hans H. Maurer
      Drug Metabolism and Disposition April 2004, 32 (4) 379-381; DOI: https://doi.org/10.1124/dmd.32.4.379

  3. Pearson, Andrew

    1. ASSESSMENT OF ARGININE 97 AND LYSINE 72 AS DETERMINANTS OF SUBSTRATE SPECIFICITY IN CYTOCHROME P450 2C9 (CYP2C9)
      Carwyn Davies, Katey Witham, Justin R. Scott, Andrew Pearson, James J. DeVoss, Sandra E. Graham and Elizabeth M. J. Gillam
      Drug Metabolism and Disposition April 2004, 32 (4) 431-436; DOI: https://doi.org/10.1124/dmd.32.4.431

  4. Phillips, Brian

    1. QUANTITATIVE CONTRIBUTION OF CYP2D6 AND CYP3A TO OXYCODONE METABOLISM IN HUMAN LIVER AND INTESTINAL MICROSOMES
      Bojan Lalovic, Brian Phillips, Linda L. Risler, William Howald and Danny D. Shen
      Drug Metabolism and Disposition April 2004, 32 (4) 447-454; DOI: https://doi.org/10.1124/dmd.32.4.447

  5. Ponimaskin, Evgeni G.

    1. EXPRESSION STUDIES AND FUNCTIONAL CHARACTERIZATION OF RENAL HUMAN ORGANIC ANION TRANSPORTER 1 ISOFORMS
      Andrew Bahn, Christian Ebbinghaus, Diana Ebbinghaus, Evgeni G. Ponimaskin, Laszlo Fuzesï, Gerhard Burckhardt and Yohannes Hagos
      Drug Metabolism and Disposition April 2004, 32 (4) 424-430; DOI: https://doi.org/10.1124/dmd.32.4.424

  6. Prough, Russell A.

    1. TRANSCRIPTIONAL SUPPRESSION OF CYTOCHROME P450 GENES BY ENDOGENOUS AND EXOGENOUS CHEMICALS
      David S. Riddick, Chunja Lee, Anahita Bhathena, Yoav E. Timsit, Po-Yung Cheng, Edward T. Morgan, Russell A. Prough, Sharon L. Ripp, Kristy K. Michael Miller, Asmeen Jahan and John Y. L. Chiang
      Drug Metabolism and Disposition April 2004, 32 (4) 367-375; DOI: https://doi.org/10.1124/dmd.32.4.367

R

  1. Riddick, David S.

    1. TRANSCRIPTIONAL SUPPRESSION OF CYTOCHROME P450 GENES BY ENDOGENOUS AND EXOGENOUS CHEMICALS
      David S. Riddick, Chunja Lee, Anahita Bhathena, Yoav E. Timsit, Po-Yung Cheng, Edward T. Morgan, Russell A. Prough, Sharon L. Ripp, Kristy K. Michael Miller, Asmeen Jahan and John Y. L. Chiang
      Drug Metabolism and Disposition April 2004, 32 (4) 367-375; DOI: https://doi.org/10.1124/dmd.32.4.367

  2. Ripp, Sharon L.

    1. TRANSCRIPTIONAL SUPPRESSION OF CYTOCHROME P450 GENES BY ENDOGENOUS AND EXOGENOUS CHEMICALS
      David S. Riddick, Chunja Lee, Anahita Bhathena, Yoav E. Timsit, Po-Yung Cheng, Edward T. Morgan, Russell A. Prough, Sharon L. Ripp, Kristy K. Michael Miller, Asmeen Jahan and John Y. L. Chiang
      Drug Metabolism and Disposition April 2004, 32 (4) 367-375; DOI: https://doi.org/10.1124/dmd.32.4.367

  3. Risler, Linda L.

    1. QUANTITATIVE CONTRIBUTION OF CYP2D6 AND CYP3A TO OXYCODONE METABOLISM IN HUMAN LIVER AND INTESTINAL MICROSOMES
      Bojan Lalovic, Brian Phillips, Linda L. Risler, William Howald and Danny D. Shen
      Drug Metabolism and Disposition April 2004, 32 (4) 447-454; DOI: https://doi.org/10.1124/dmd.32.4.447

S

  1. Sakuma, Tsutomu

    1. CLONING CYP2D21 AND CYP3A22 CDNAS FROM LIVER OF MINIATURE PIGS
      Tsutomu Sakuma, Tsukasa Shimojima, Kiyoshi Miwa and Tetsuya Kamataki
      Drug Metabolism and Disposition April 2004, 32 (4) 376-378; DOI: https://doi.org/10.1124/dmd.32.4.376

  2. Scott, Justin R.

    1. ASSESSMENT OF ARGININE 97 AND LYSINE 72 AS DETERMINANTS OF SUBSTRATE SPECIFICITY IN CYTOCHROME P450 2C9 (CYP2C9)
      Carwyn Davies, Katey Witham, Justin R. Scott, Andrew Pearson, James J. DeVoss, Sandra E. Graham and Elizabeth M. J. Gillam
      Drug Metabolism and Disposition April 2004, 32 (4) 431-436; DOI: https://doi.org/10.1124/dmd.32.4.431

  3. Shen, Danny D.

    1. QUANTITATIVE CONTRIBUTION OF CYP2D6 AND CYP3A TO OXYCODONE METABOLISM IN HUMAN LIVER AND INTESTINAL MICROSOMES
      Bojan Lalovic, Brian Phillips, Linda L. Risler, William Howald and Danny D. Shen
      Drug Metabolism and Disposition April 2004, 32 (4) 447-454; DOI: https://doi.org/10.1124/dmd.32.4.447

  4. Shimojima, Tsukasa

    1. CLONING CYP2D21 AND CYP3A22 CDNAS FROM LIVER OF MINIATURE PIGS
      Tsutomu Sakuma, Tsukasa Shimojima, Kiyoshi Miwa and Tetsuya Kamataki
      Drug Metabolism and Disposition April 2004, 32 (4) 376-378; DOI: https://doi.org/10.1124/dmd.32.4.376

  5. Springer, Dietmar

    1. IDENTIFICATION OF HUMAN CYTOCHROME P450 2D6 AS MAJOR ENZYME INVOLVED IN THE O-DEMETHYLATION OF THE DESIGNER DRUG P-METHOXYMETHAMPHETAMINE
      Roland F. Staack, Denis S. Theobald, Liane D. Paul, Dietmar Springer, Thomas Kraemer and Hans H. Maurer
      Drug Metabolism and Disposition April 2004, 32 (4) 379-381; DOI: https://doi.org/10.1124/dmd.32.4.379

  6. Staack, Roland F.

    1. IDENTIFICATION OF HUMAN CYTOCHROME P450 2D6 AS MAJOR ENZYME INVOLVED IN THE O-DEMETHYLATION OF THE DESIGNER DRUG P-METHOXYMETHAMPHETAMINE
      Roland F. Staack, Denis S. Theobald, Liane D. Paul, Dietmar Springer, Thomas Kraemer and Hans H. Maurer
      Drug Metabolism and Disposition April 2004, 32 (4) 379-381; DOI: https://doi.org/10.1124/dmd.32.4.379

T

  1. Talaat, Rasmy E.

    1. INCORPORATION OF AN OXYGEN FROM WATER INTO TROGLITAZONE QUINONE BY CYTOCHROME P450 AND MYELOPEROXIDASE
      Kan He, Rasmy E. Talaat and Thomas F. Woolf
      Drug Metabolism and Disposition April 2004, 32 (4) 442-446; DOI: https://doi.org/10.1124/dmd.32.4.442

  2. Tchernof, André

    1. AMINO ACID RESIDUE ILE211 IS ESSENTIAL FOR THE ENZYMATIC ACTIVITY OF HUMAN UDP-GLUCURONOSYLTRANSFERASE 1A10 (UGT1A10)
      Isabelle Martineau, André Tchernof and Alain Bélanger
      Drug Metabolism and Disposition April 2004, 32 (4) 455-459; DOI: https://doi.org/10.1124/dmd.32.4.455

  3. Theobald, Denis S.

    1. IDENTIFICATION OF HUMAN CYTOCHROME P450 2D6 AS MAJOR ENZYME INVOLVED IN THE O-DEMETHYLATION OF THE DESIGNER DRUG P-METHOXYMETHAMPHETAMINE
      Roland F. Staack, Denis S. Theobald, Liane D. Paul, Dietmar Springer, Thomas Kraemer and Hans H. Maurer
      Drug Metabolism and Disposition April 2004, 32 (4) 379-381; DOI: https://doi.org/10.1124/dmd.32.4.379

  4. Timsit, Yoav E.

    1. TRANSCRIPTIONAL SUPPRESSION OF CYTOCHROME P450 GENES BY ENDOGENOUS AND EXOGENOUS CHEMICALS
      David S. Riddick, Chunja Lee, Anahita Bhathena, Yoav E. Timsit, Po-Yung Cheng, Edward T. Morgan, Russell A. Prough, Sharon L. Ripp, Kristy K. Michael Miller, Asmeen Jahan and John Y. L. Chiang
      Drug Metabolism and Disposition April 2004, 32 (4) 367-375; DOI: https://doi.org/10.1124/dmd.32.4.367

  5. Toth, Lisa N.

    1. COMPARISON OF PREDICTION METHODS FOR IN VIVO CLEARANCE OF (S,S)-3-[3-(METHYLSULFONYL)PHENYL]-1-PROPYLPIPERIDINE HYDROCHLORIDE, A DOPAMINE D2 RECEPTOR ANTAGONIST, IN HUMANS
      Shinji Yamazaki, Lisa N. Toth, Meredith L. Black and J. Neil Duncan
      Drug Metabolism and Disposition April 2004, 32 (4) 398-404; DOI: https://doi.org/10.1124/dmd.32.4.398

  6. Tsai, Pi-Lo

    1. HEPATOBILIARY EXCRETION OF BERBERINE
      Pi-Lo Tsai and Tung-Hu Tsai
      Drug Metabolism and Disposition April 2004, 32 (4) 405-412; DOI: https://doi.org/10.1124/dmd.32.4.405

  7. Tsai, Tung-Hu

    1. HEPATOBILIARY EXCRETION OF BERBERINE
      Pi-Lo Tsai and Tung-Hu Tsai
      Drug Metabolism and Disposition April 2004, 32 (4) 405-412; DOI: https://doi.org/10.1124/dmd.32.4.405

U

  1. Uchaipichat, Verawan

    1. HUMAN UDP-GLUCURONOSYLTRANSFERASES: ISOFORM SELECTIVITY AND KINETICS OF 4-METHYLUMBELLIFERONE AND 1-NAPHTHOL GLUCURONIDATION, EFFECTS OF ORGANIC SOLVENTS, AND INHIBITION BY DICLOFENAC AND PROBENECID
      Verawan Uchaipichat, Peter I. Mackenzie, Xiao-Hui Guo, Dione Gardner-Stephen, Aleksandra Galetin, J. Brian Houston and John O. Miners
      Drug Metabolism and Disposition April 2004, 32 (4) 413-423; DOI: https://doi.org/10.1124/dmd.32.4.413

V

  1. van Breemen, Richard B.

    1. NEW METABOLIC PATHWAYS FOR FLAVANONES CATALYZED BY RAT LIVER MICROSOMES
      Dejan Nikolic and Richard B. van Breemen
      Drug Metabolism and Disposition April 2004, 32 (4) 387-397; DOI: https://doi.org/10.1124/dmd.32.4.387

W

  1. Welham, K. J.

    1. A PROTEOMIC APPROACH TO THE IDENTIFICATION OF CYTOCHROME P450 ISOFORMS IN MALE AND FEMALE RAT LIVER BY NANOSCALE LIQUID CHROMATOGRAPHY-ELECTROSPRAY IONIZATION-TANDEM MASS SPECTROMETRY
      S. Nisar, C. S. Lane, A. F. Wilderspin, K. J. Welham, W. J. Griffiths and L. H. Patterson
      Drug Metabolism and Disposition April 2004, 32 (4) 382-386; DOI: https://doi.org/10.1124/dmd.32.4.382

  2. Wilderspin, A. F.

    1. A PROTEOMIC APPROACH TO THE IDENTIFICATION OF CYTOCHROME P450 ISOFORMS IN MALE AND FEMALE RAT LIVER BY NANOSCALE LIQUID CHROMATOGRAPHY-ELECTROSPRAY IONIZATION-TANDEM MASS SPECTROMETRY
      S. Nisar, C. S. Lane, A. F. Wilderspin, K. J. Welham, W. J. Griffiths and L. H. Patterson
      Drug Metabolism and Disposition April 2004, 32 (4) 382-386; DOI: https://doi.org/10.1124/dmd.32.4.382

  3. Witham, Katey

    1. ASSESSMENT OF ARGININE 97 AND LYSINE 72 AS DETERMINANTS OF SUBSTRATE SPECIFICITY IN CYTOCHROME P450 2C9 (CYP2C9)
      Carwyn Davies, Katey Witham, Justin R. Scott, Andrew Pearson, James J. DeVoss, Sandra E. Graham and Elizabeth M. J. Gillam
      Drug Metabolism and Disposition April 2004, 32 (4) 431-436; DOI: https://doi.org/10.1124/dmd.32.4.431

  4. Woolf, Thomas F.

    1. INCORPORATION OF AN OXYGEN FROM WATER INTO TROGLITAZONE QUINONE BY CYTOCHROME P450 AND MYELOPEROXIDASE
      Kan He, Rasmy E. Talaat and Thomas F. Woolf
      Drug Metabolism and Disposition April 2004, 32 (4) 442-446; DOI: https://doi.org/10.1124/dmd.32.4.442

Y

  1. Yamagami, Saeko

    1. KEY STRUCTURAL FEATURES OF LIGANDS FOR ACTIVATION OF HUMAN PREGNANE X RECEPTOR
      Kaoru Kobayashi, Saeko Yamagami, Tomoaki Higuchi, Masakiyo Hosokawa and Kan Chiba
      Drug Metabolism and Disposition April 2004, 32 (4) 468-472; DOI: https://doi.org/10.1124/dmd.32.4.468

  2. Yamazaki, Shinji

    1. COMPARISON OF PREDICTION METHODS FOR IN VIVO CLEARANCE OF (S,S)-3-[3-(METHYLSULFONYL)PHENYL]-1-PROPYLPIPERIDINE HYDROCHLORIDE, A DOPAMINE D2 RECEPTOR ANTAGONIST, IN HUMANS
      Shinji Yamazaki, Lisa N. Toth, Meredith L. Black and J. Neil Duncan
      Drug Metabolism and Disposition April 2004, 32 (4) 398-404; DOI: https://doi.org/10.1124/dmd.32.4.398
Back to top

In this issue